The Children's Cancer Research Institute and the European Neuroblastoma Research Network (SIOPEN) grants Apeiron exclusive, worldwide rights to ch14.18 for cancer

Children's Cancer Research Institute

Austria / Non-Profit or Major Disease Foundation

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Society of Paediatric Oncology European Neuroblastoma Research Network

Austria / Non-Profit or Major Disease Foundation

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Apeiron Biologics AG

Austria / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced